The Post-COVID Shedding Wave: Telogen Effluvium After Infection

Post-COVID telogen effluvium was one of the most frequently reported post-COVID symptoms globally. The biology is straightforward — severe illness triggers follicle shutdown — but the interaction with underlying AGA adds a layer that is rarely addressed.

Post-COVID telogen effluvium became one of the best-documented large-scale hair loss events in clinical history, providing an inadvertent natural experiment on the biology of stress-triggered TE. Understanding the mechanism confirms foundational follicle biology and has implications for men with underlying AGA who experienced COVID-related shedding.

The telogen effluvium mechanism

The hair follicle cycle responds to systemic physiological stress by moving follicles into telogen — the rest phase — as a resource-conservation measure. During severe illness, the body prioritises energy toward immune function and vital organ support, reducing energy allocation to non-essential processes like hair production. DHT, cortisol, and the inflammatory cytokines of acute illness (IL-6, TNF-α) all independently promote catagen entry and telogen maintenance.

The result: a synchronised cohort of follicles enters telogen during the illness. Approximately two to three months later — the normal telogen duration — they shed simultaneously, producing the dramatic sudden-onset diffuse shedding that characterises acute telogen effluvium. The shedding peak is not during the illness but months afterward, which initially confused patients and clinicians who did not connect the episode to the prior infection.

COVID-specific features

COVID-19 produced TE via multiple concurrent mechanisms: the febrile illness itself, the significant inflammatory cytokine response (including IL-6 and IL-1β elevations that directly affect follicle cycling), nutritional compromise during hospitalisation or reduced appetite, psychological stress, and — in severe cases — hypoxic stress from pulmonary involvement. The multiplicity of TE triggers explains why post-COVID TE was often more severe and prolonged than typical single-cause TE.

AGA interaction and the acceleration concern

For men with pre-existing AGA, post-COVID TE has a specific clinical concern: the acute shedding episode may include miniaturised AGA-susceptible follicles that were in early stages of progressive miniaturisation. Once shed and re-entering anagen, these follicles resume the DHT-driven miniaturisation process — and the post-TE anagen hairs may be thinner and shorter than pre-COVID hairs in AGA zones, reflecting AGA progression that would have occurred more gradually without the acute shedding event.

Men who notice that their hair did not fully recover to pre-COVID density — particularly in vertex or frontal zones — after the TE component has resolved (typically 6–12 months post-infection) should be evaluated for AGA. The COVID episode may have unmasked or accelerated underlying pattern loss that was subclinical before the acute event.